Upcoming Clinical Trial: Low-Dose Psilocybin for Anxiety
We are excited to announce that we are currently planning a clinical trial investigating the effects of low doses of psilocybin as a potential treatment for anxiety. This innovative study aims to explore safety, tolerability, and preliminary effectiveness to help develop new therapeutic options for those affected by anxiety disorders. We are currently seeking funding to support this important clinical trial on low-dose psilocybin for anxiety.
Contract Research Opportunities in Preclinical and Clinical Trials
We are open to conducting contract research services in both rodent models and clinical trials. We have a potential partner ready to support these projects. Denmark offers a highly favorable environment for clinical trials, making it an ideal location for innovative research collaborations.